FDA’s AI Healthcare Shift: Speeding Innovation
The FDA eases oversight for low-risk AI clinical decision support software and wearables. This aims to spur digital health innovation by exempting such tools from rigorous pre-market reviews if they support, rather than replace, human clinical judgment.
Read More